Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study to Assess the Efficacy and Safety of REGN3500 Monotherapy, and Combination of REGN3500 Plus Dupilumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis (229183)


Collapse Overview 
Collapse sponsor award id
R3500-AD


Collapse Biography 

Collapse Time 
Collapse start date
2019-09-26